Similarly, FGFR1 alternative FGFR1α/FGFR1β splicing was found to play a key role in breast cancer [34] and FGFR3 splicing promoted aggressiveness in prostate cancer [125]. This evidence concerns the gene FGFR1 and prostate carcinoma.